Komori
Alfresa Holdings (2784) · FactFirst stated

FY2022-Q2: Medical-related business revenue growth and continued operating loss

First written in FY2022-Q2. . Latest entry: FY2022-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Healthcare-Related Business: Revenue Growth and Continued Operating LossesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022-Q2First statedAnnual report

    「当セグメントの当第２四半期連結累計期間の業績は、合併による店舗数の増加、薬価改定および新型コロナウイルス感染拡大等の影響により、売上高167億99百万円（前年同期は166億9百万円）、営業損失2億85百万円（同2億89百万円）となりました。」

    医療関連事業は合併による店舗数増加等により増収となった一方、営業損失が継続した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.